Novavax, Inc. (NASDAQ:NVAX) traded at $12.62 at close of the session on current trade day and made an upward move of 0.72% on its previous day’s price. Looking at the stock we see that its previous close was $12.53 and the beta (5Y monthly) reads
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
